Elan's once-daily verapamil
Executive Summary
Irish controlled-release R&D firm announces filing of additional clinical data on its one-a-day calcium channel blocker. Elan also says it is in "the final stage" of clinicals for a once-daily version of nifedipine, for which it expects to file an NDA in early 1989....